...
首页> 外文期刊>International Journal of Biomedical and Advance Research >Evaluation of platelet count and platelet indices in patients with coronary artery disease
【24h】

Evaluation of platelet count and platelet indices in patients with coronary artery disease

机译:冠心病患者血小板计数和血小板指数的评估

获取原文
           

摘要

Background: Ischemic heart disease is mainly caused by atherosclerosis and its complications. Platelets and their activity have an important role in initiation of atherosclerotic lesions and coronary thrombus formation. Larger platelets are enzymatically and metabolically more active and have a higher potential thrombotic ability as compared with smaller platelets. Aims: To study the changes in platelet volume indices and platelet count in ischaemic heart disease and assess their usefulness in predicting coronary events. Methods: This was a comparative study of 180 patients (60 patients with stable angina, 60 with acute coronary syndrome and 60 with non-cardiac chest pain). Blood venous sample were drawn from all subjects after admission and collected in EDTA tubes. Platelet count and volume indices were assayed within 30 min of blood collection, using Nihon Kohden autoanalyzer. Results : All platelet volume indicesmean platelet volume (MPV), platelet distribution width (PDW), and platelet concentrate (PCT)were significantly raised in patients with AMI and UA. In patients with myocardial infarction, the mean values of MPV, PDW, platelet count and PCT were 11.02fL, 17.85%, 2.61 lac/cumm and 0.34% respectively. In patients with unstable angina were 10.31fL, 16.75%, 2.3 lac/cumm and 0.36% respectively while in normal healthy control the mean values of these indices were 7.98 fL, 10.70%, 2.66 lac/cumm and 0.24% respectively. Conclusions: Patients with acute coronary syndrome had higher platelet volume indices and lower platelet counts compared with those with stable angina and the normal population. Measurements of platelet volume indices and platelet count may be of some benefit in detecting those patients at higher risk for acute coronary events.
机译:背景:缺血性心脏病主要由动脉粥样硬化及其并发症引起。血小板及其活性在引发动脉粥样硬化病变和形成冠状血栓方面具有重要作用。与较小的血小板相比,较大的血小板在酶和代谢上更具活性,并且具有更高的潜在血栓形成能力。目的:研究缺血性心脏病中血小板体积指数和血小板计数的变化,并评估其在预测冠脉事件中的作用。方法:这是一项对180例患者的比较研究(60例稳定型心绞痛,60例急性冠状动脉综合征和60例非心源性胸痛)。入院后从所有受试者中抽取静脉血样本,并收集在EDTA管中。使用Nihon Kohden自动分析仪在采血30分钟内测定血小板计数和体积指数。结果:AMI和UA患者的所有血小板体积指数均指血小板体积(MPV),血小板分布宽度(PDW)和血小板浓缩物(PCT)显着升高。在患有心肌梗塞的患者中,MPV,PDW,血小板计数和PCT的平均值分别为11.02fL,17.85%,2.61 lac / cum和0.34%。不稳定型心绞痛患者分别为10.31fL,16.75%,2.3 lac / cum和0.36%,而在正常健康对照组中,这些指数的平均值分别为7.98fL,10.70%,2.66 lac / cum和0.24%。结论:与稳定型心绞痛和正常人群相比,急性冠脉综合征患者的血小板体积指数更高,血小板计数更低。血小板体积指数和血小板计数的测量可能对检测那些急性冠脉事件风险较高的患者有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号